These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
922 related articles for article (PubMed ID: 32153565)
1. Current Challenges in the Identification of Pre-Erythrocytic Malaria Vaccine Candidate Antigens. Bettencourt P Front Immunol; 2020; 11():190. PubMed ID: 32153565 [No Abstract] [Full Text] [Related]
2. Liver-Directed AAV8 Booster Vaccine Expressing Shahnaij M; Iyori M; Mizukami H; Kajino M; Yamagoshi I; Syafira I; Yusuf Y; Fujiwara K; Yamamoto DS; Kato H; Ohno N; Yoshida S Front Immunol; 2021; 12():612910. PubMed ID: 34248928 [TBL] [Abstract][Full Text] [Related]
3. Novel sporozoite-based ELISpot assay to assess frequency of parasite-specific B cells after vaccination with irradiated sporozoites. Atre T; Robinson TM; Savransky T; Dutta S; Epstein JE; Bergmann-Leitner ES Malar J; 2019 May; 18(1):186. PubMed ID: 31142328 [TBL] [Abstract][Full Text] [Related]
4. Importance of the Immunodominant CD8 Gibbins MP; Müller K; Glover M; Liu J; Putrianti ED; Bauza K; Reyes-Sandoval A; Matuschewski K; Silvie O; Hafalla JCR Infect Immun; 2020 Sep; 88(10):. PubMed ID: 32719159 [TBL] [Abstract][Full Text] [Related]
11. Live attenuated pre-erythrocytic malaria vaccines. Keitany GJ; Vignali M; Wang R Hum Vaccin Immunother; 2014; 10(10):2903-9. PubMed ID: 25483648 [TBL] [Abstract][Full Text] [Related]
12. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells. Tarun AS; Dumpit RF; Camargo N; Labaied M; Liu P; Takagi A; Wang R; Kappe SH J Infect Dis; 2007 Aug; 196(4):608-16. PubMed ID: 17624848 [TBL] [Abstract][Full Text] [Related]
13. Sporozoite immunization of human volunteers under chemoprophylaxis induces functional antibodies against pre-erythrocytic stages of Plasmodium falciparum. Behet MC; Foquet L; van Gemert GJ; Bijker EM; Meuleman P; Leroux-Roels G; Hermsen CC; Scholzen A; Sauerwein RW Malar J; 2014 Apr; 13():136. PubMed ID: 24708526 [TBL] [Abstract][Full Text] [Related]
14. Pre-erythrocytic immunity to Plasmodium falciparum: the case for an LSA-1 vaccine. Kurtis JD; Hollingdale MR; Luty AJ; Lanar DE; Krzych U; Duffy PE Trends Parasitol; 2001 May; 17(5):219-23. PubMed ID: 11323304 [TBL] [Abstract][Full Text] [Related]
15. The march toward malaria vaccines. Hoffman SL; Vekemans J; Richie TL; Duffy PE Vaccine; 2015 Nov; 33 Suppl 4(Suppl 4):D13-23. PubMed ID: 26324116 [TBL] [Abstract][Full Text] [Related]
16. Assessing the adequacy of attenuation of genetically modified malaria parasite vaccine candidates. Annoura T; Ploemen IH; van Schaijk BC; Sajid M; Vos MW; van Gemert GJ; Chevalley-Maurel S; Franke-Fayard BM; Hermsen CC; Gego A; Franetich JF; Mazier D; Hoffman SL; Janse CJ; Sauerwein RW; Khan SM Vaccine; 2012 Mar; 30(16):2662-70. PubMed ID: 22342550 [TBL] [Abstract][Full Text] [Related]
17. The Development of Whole Sporozoite Vaccines for Itsara LS; Zhou Y; Do J; Grieser AM; Vaughan AM; Ghosh AK Front Immunol; 2018; 9():2748. PubMed ID: 30619241 [TBL] [Abstract][Full Text] [Related]
18. Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection. Cummings JF; Spring MD; Schwenk RJ; Ockenhouse CF; Kester KE; Polhemus ME; Walsh DS; Yoon IK; Prosperi C; Juompan LY; Lanar DE; Krzych U; Hall BT; Ware LA; Stewart VA; Williams J; Dowler M; Nielsen RK; Hillier CJ; Giersing BK; Dubovsky F; Malkin E; Tucker K; Dubois MC; Cohen JD; Ballou WR; Heppner DG Vaccine; 2010 Jul; 28(31):5135-44. PubMed ID: 19737527 [TBL] [Abstract][Full Text] [Related]
19. RTS,S vaccination is associated with serologic evidence of decreased exposure to Plasmodium falciparum liver- and blood-stage parasites. Campo JJ; Aponte JJ; Skinner J; Nakajima R; Molina DM; Liang L; Sacarlal J; Alonso PL; Crompton PD; Felgner PL; Dobaño C Mol Cell Proteomics; 2015 Mar; 14(3):519-31. PubMed ID: 25547414 [TBL] [Abstract][Full Text] [Related]
20. Efficacy model for antibody-mediated pre-erythrocytic malaria vaccines. White MT; Griffin JT; Riley EM; Drakeley CJ; Moorman AM; Sumba PO; Kazura JW; Ghani AC; John CC Proc Biol Sci; 2011 May; 278(1710):1298-305. PubMed ID: 20943696 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]